Next-generation sequencing (NGS) technologies are enabling a more personalized approach to the treatment of ovarian cancer. By analyzing the genetic mutations present in an individual patient's tumor, oncologists can identify targeted therapies that are most likely to be effective. This precision medicine approach not only increases the chances of successful treatment but also minimizes the risk of adverse side effects, offering hope to women battling this challenging disease.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.